Nicotine formulation
US11833145B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Inventors
Key dates
| Filing date | May 31, 2019 |
| Grant date | Dec 5, 2023 |
| Priority date | — |
| Expiry date | Dec 8, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M15/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a pharmaceutical formulation comprising nicotine. The formulation can be aerosolised at ambient temperature for delivery via inhalation. The invention also relates to a method of delivering nicotine to a subject via inhalation, and specifically via the use of a nebuliser.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.